Source:http://linkedlifedata.com/resource/pubmed/id/16713435
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-5-22
|
pubmed:abstractText |
Statins improve all major lipid fractions, reduce coronary heart disease risk, and may have a minor effect on glucose tolerance. A reduction in free fatty acid flux and concentrations could be partly responsible for these effects. We measured nocturnal and postprandial plasma palmitate concentrations and rate of appearance (R(a)) on 2 occasions in 12 obese dyslipidemic subjects with type 2 diabetes mellitus, using a single-blind, crossover format (placebo followed by simvastatin, 80 mg/d), and also on 1 occasion in 6 untreated control subjects. The diabetic subjects had increased average nocturnal (127+/-13 vs 80+/-10 micromol/L, P<.05) and 2-hour postprandial (49+/-6 vs 17+/-2 micromol/L, P<.001) palmitate concentrations, as well as increased nocturnal (31.6+/-3.7 vs 19.5+/-3.7 mmol/m(2) over 9 hours, P<.05) and postprandial (11.5+/-3.7 vs 5.5+/-3.7 mmol/m(2) every 4 hours, P<.005) integrated palmitate R(a) compared to normal controls. High-dose simvastatin reduced serum triglycerides by 35% but had no effect on plasma palmitate concentrations or R(a). These results suggest that the triglyceride-lowering effect of statins is not mediated through an effect on FFA metabolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0026-0495
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
758-62
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16713435-Adult,
pubmed-meshheading:16713435-Cross-Over Studies,
pubmed-meshheading:16713435-Diabetes Mellitus, Type 2,
pubmed-meshheading:16713435-Fatty Acids, Nonesterified,
pubmed-meshheading:16713435-Female,
pubmed-meshheading:16713435-Humans,
pubmed-meshheading:16713435-Lipid Metabolism,
pubmed-meshheading:16713435-Male,
pubmed-meshheading:16713435-Middle Aged,
pubmed-meshheading:16713435-Palmitates,
pubmed-meshheading:16713435-Simvastatin,
pubmed-meshheading:16713435-Single-Blind Method,
pubmed-meshheading:16713435-Triglycerides
|
pubmed:year |
2006
|
pubmed:articleTitle |
The effect of high-dose simvastatin on free fatty acid metabolism in patients with type 2 diabetes mellitus.
|
pubmed:affiliation |
Endocrine Research Unit, Division of Endocrinology, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA. isley.william@mayo.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|